FDA Announces Recall of Lidocaine HCI Injection by Hospira:...
On April 18, the FDA announced that one lot of Lidocaine HCI Injection, USP, by Hospira, is recalled due to visible particulates embedded in the glass vial. In light of this news, AttorneyOne, a...(PRWeb April 28, 2014)Read the full story at http://www.prweb.com/releases/2014/04/prweb11800269.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 28, 2014 Category: Pharmaceuticals Source Type: news
Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates
Risk of local inflammation, and/or mechanical disruption of tissue or immune response to the particulate, and/or a delay in therapy. (Source: FDA MedWatch)
Source: FDA MedWatch - April 18, 2014 Category: American Health Source Type: news
Synera (Lidocaine and Tetracaine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 28, 2014 Category: Drugs & Pharmacology Source Type: news
Merit Medical Systems, Custom Procedural Trays/Kits Containing 1 percent Lidocaine HCl Injection, USP, 10mg/mL: Recall - Particulates Found in Hospira supplied Lidocaine
Presence of oxidized stainless steel particulate may put a patient at risk from strong magnetic field exposure such as MRI, and other adverse events resulting in serious life-threatening complications. (Source: FDA MedWatch)
Source: FDA MedWatch - March 14, 2014 Category: American Health Source Type: news
Merit Medical gets FDA's highest-risk label over Hospira injections
FDA regulators put their highest-risk label on Merit Medical's recall of kits containing 1% Lidocaine HCl injections manufactured by Hospira.
Food & Drug Administration (FDA), Hospira Inc., Merit Medical Systems Inc.News Well, Food & Drug Administration (FDA), Recallsread more (Source: Mass Device)
Source: Mass Device - March 13, 2014 Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news
Class I Medical Device Recall: Merit Medical Systems, Custom Procedural Trays/Kits Containing 1% Lidocaine HCl Injection, USP, 10mg/mL - Particulates Found in Hospira supplied 1% Lidocaine HCl
Custom procedural trays or kits are a combination of legally marketed medical devices placed into one container for the convenience of the user and used within the limits of the products? intended uses. (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - March 13, 2014 Category: Medical Equipment Source Type: news
Use of Lidocaine for Analgesia in Children and AdolescentsUse of Lidocaine for Analgesia in Children and Adolescents
Are lidocaine patches and infusions safe for pediatric patients? Pediatric Pharmacotherapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 10, 2014 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news
TPR Podcast Episode #2: Chinese Restaurant Toxicology
Conclusion: patients with renal dysfunction should be cautious of how much durian they ingest
Summary of Soy Sauce Induced
19 year old male came in comatose after being dared to ingesting a quart of soy sauce 2 hrs prior to arrival
Peak sodium 196
The patient received very aggressive fluid hydration
6L D5W
Soy sauce is 17-18% NaCl
A quart of soy sauce has 160-170gm ~ 10tbsp of NaCl
The only critique of the paper is that the use of very aggressive fluid hydration and lowering of sodium should not be generalized to all cases given the risk of central pontine myelinolysis
In this case extreme measures and aggressi...
Source: The Poison Review - February 22, 2014 Category: Toxicology Authors: LeonThe Poison Review Tags: Podcast Source Type: news
lidocaine HCl injection, Xylocaine
Title: lidocaine HCl injection, XylocaineCategory: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 2/7/2014 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - February 7, 2014 Category: Drugs & Pharmacology Source Type: news
Lidocaine Injection Recalled in 28 StatesLidocaine Injection Recalled in 28 States
Hospira Inc has recalled a single lot of lidocaine HCI injection because of the presence of reddish-orange particles in glass vials; no adverse events have been reported to date. News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 24, 2013 Category: Consumer Health News Tags: Anesthesiology News Alert Source Type: news
Lidocaine HCl Injection 2%, 5 ml Vial by Hospira: Recall - Presence of Particulate Matter
If infused, particulate matter could lead to local inflammation, tissue trauma, mechanical disruption of tissue, and/or local granuloma formulation. (Source: FDA MedWatch)
Source: FDA MedWatch - December 24, 2013 Category: American Health Source Type: news
Absorption Pharma and Kaiser to assess efficacy of Promescent in Phase III premature ejaculation study
Absorption Pharmaceuticals (AP) in collaboration with Kaiser Permanente has started a double blind, placebo-controlled, randomised Phase III clinical trial to assess the efficacy of 'Promescent lidocaine spray' for men with premature ejaculation (PE)… (Source: Drug Development Technology)
Source: Drug Development Technology - December 13, 2013 Category: Pharmaceuticals Source Type: news
Pliaglis (Lidocaine and Tetracaine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 12, 2013 Category: Drugs & Pharmacology Source Type: news
Consumer Information on: Juvéderm Voluma XC - P110033
Juvéderm Voluma XC is a sterile, biodegradable, viscoelastic gel implant. It consists of crosslinked hyaluronic acid produced by Streptococcus equi bacteria, formulated to a concentration of 20 mg/mL with 0.3% lidocaine. (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - November 20, 2013 Category: Medical Equipment Source Type: news
FDA Okays Cheek Volume Filler Juvederm Voluma XCFDA Okays Cheek Volume Filler Juvederm Voluma XC
Juvederm Voluma XC is a viscous gel composed of cross-linked hyaluronic acid suspended in phosphate-buffered saline with 0.3% lidocaine for correction of age-related volume deficits in the midface. FDA Approvals (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 23, 2013 Category: Consumer Health News Tags: Plastic Surgery & Aesthetic Medicine News Alert Source Type: news
